OUR CUTTING-EDGE PRODUCTS
Early Detection of Cancer Tests
The early detection tests are applied to individuals who have a high risk to develop cancer, e.g., due to a family history or genetic predisposition.
Due to their outstanding diagnostic precision, these tests have high potential to be used for population-wide screening in the long term.
enable erlier detection of pre-malignant lesions and cancer of the ovaries, fallopian tubes or the endometrium;
enable timely detection of primary and relapsed cancer so that curative measures are still possible;
guide physicians selecting the most appropriate therapy for each individual patient;
run on commercially available analysis platforms.
The Immune Signature Tests are non-invasive and are based on novel concepts ensuring unprecedented sensitivity and specificity. Proof-of-principle studies were performed for ovarian, breast and pancreatic cancer. The test principles allow application in other major types of cancer.
The LOC Test detects pre-malignant and malignant cells of ovarian cancer and endometrial cancer. The cells are collected from the uterine cavity with the specially designed and propietory Speiser Catheter.